Skip to content

The effect of xylocaine gel versus dry speculum on cytology adequacy among women undergoing Pap smear screening ;A randomized controlled study.

The effect of xylocaine gel versus dry speculum on cytology adequacy among women undergoing Pap smear screening ;A randomized controlled study.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
PACTR
Registry ID
PACTR202606770457238
Enrollment
2014
Registered
2026-06-26
Start date
2026-07-13
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer screening

Interventions

Dry speculum

Sponsors

Prof. Leonard Ogbonna Ajah
Lead Sponsor
Prof. George O. Ugwu
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: ?women aged between 25 and 65 years in line with cervical cancer screening guidelines. ?Those scheduled for Pap smear screening during the study period. ?Women willing to provide written informed consent ?Women with no douching or vaginal medications for the preceding 48 hours ?Women who had no sexual intercourse for the preceding 48 hours

Exclusion criteria

Exclusion criteria: ?Women that were virgins ?Pregnant women ? Recent sexual intercourse ?Those with obvious cervical pathology. ?Women with active pelvic infection, cervicitis, or vaginitis, which can confound pain reporting. ?Women on hormone replacement therapy ?Those with a history of cervical surgery (e.g., LEEP, cone biopsy) or pelvic radiation, which may alter anatomy or sensation. ?Women with known allergy or hypersensitivity to lidocaine or any component of the gel. ?Recent use (within 24 hours) of systemic analgesics, sedatives, or local anaesthetics that could influence pain scoring.

Design outcomes

Primary

MeasureTime frame
Proportion of women with satisfactory Pap smear cytology in each group.

Secondary

MeasureTime frame
1. Mean pain scores experienced during speculum insertion in each group. 2. Proportion of women willing to return for repeat Pap smear cytology testing.

Countries

Nigeria

Contacts

Public ContactGeorge Ugwu

Professor in the University of Nigeria Nsukka Nigeria

ugwugeo@yahoo.com+2348035653435

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026